Inhibition of Noxa up-regulation attenuates killing by the
ABT-737/cisplatin combination. UM-22A cells were seeded in 100-mm dishes,
grown overnight, and then transfected for 24 h with nonspecific siRNA or Noxa
siRNA, as described under Materials and Methods. The transfected
cells were either then left untreated or treated for an additional 24 h with
0.1% DMSO, 10 μM ABT-737 alone, 10 μM cisplatin alone, or ABT-737 plus
cisplatin (10 μM each). After treatment, cells were harvested and analyzed
by immunoblotting to determine Noxa protein levels. In addition, trypan blue
exclusion assays were used to determine the percentage of cell survival. The
plotted data represent the average of means from three independent
experiments, and error bars represent the S.E.M. P values were
determined using one-way ANOVA followed by Tukey's multiple comparison test.
*, P < 0.01 comparing ABT-737/cisplatin-treated cells
transfected with Noxa siRNA versus nonspecific siRNA.